Corbus Pharmaceuticals
CRBP | NASDAQ
$3.38
-$0.01 (-0.29%)
At close: Nov 16, 2026, 4:00 PM ET
$3.19
-$0.19 (-5.62%)
After-hours:
Nov 16, 2026, 7:39 PM ET
-0.29%
(1D)No price chart data available for 1D timeframe.
Rating
26
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #902/1021 (Top 88%)
Key Statistics
Market Data
Market Cap $69.55M
1D Range
3.00 3.43
52W Range
2.86 12.15
Valuation (TTM)
PE -0.53
PB 0.82
EV/EBITDA 0.36
Valuation (NTM)
Forward PE N/A
Forward PEG 0.06
Price Target $34.00
Cash Flow
FCF Yield -132.8%
SBC Adj. FCF Yield -142.8%
SBC Impact -7.5%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y N/A |
-100.0%
Dil EPS 3Y | 5Y 18.5% |
15.3%
FCF 3Y | 5Y -44.1% |
-23.9%
Returns
ROA -94.6%
ROE -101.0%
ROIC -136.8%
Financial Health
Net Cash
$115.34M
Current Ratio 3.40
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Corbus Pharmaceuticals Holdings, Inc. is an oncology company, which engages in research, development, and commercializing therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibod...
Sector Healthcare
Industry Biotechnology
Employees 36
IPO Date Oct 27, 2014
Website www.corbuspharma.com
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
7
Consensus
Buy
Price Target
$34.00
Upside
+905.92%
Buy (7)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove CRBP